Azole interactions with multidrug therapy in pediatric oncology

Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers

(2011) Gopal Krishna et al.   Expert Opinion on Drug Metabolism & Toxicology

Risk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: Old problem - New Dilemma

(2011) Zoe Dorothea Pana et al.   PEDIATRIC BLOOD & CANCER

Invasive fungal infections in pediatric oncology

(2011) Meirav Mor et al.   PEDIATRIC BLOOD & CANCER

Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone

(2010) Teijo I. Saari et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Drug interactions in childhood cancer

(2010) Cyrine Haidar et al.   LANCET ONCOLOGY

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

(2009) Roger J. M. Brüggemann et al.   CLINICAL INFECTIOUS DISEASES

Safety of triazole antifungal drugs in patients with cancer

(2009) S. Cronin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Posaconazole-increased Vincristine Neurotoxicity in a Child

(2009) Céline Eiden et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Clinically relevant drug interactions of current antifungal agents

(2009) Paul O. Gubbins et al.   MYCOSES

Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies

(2008) M. O. Karlsson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Changing epidemiology of systemic fungal infections

(2008) M. Richardson et al.   CLINICAL MICROBIOLOGY AND INFECTION

Voriconazole drastically increases exposure to oral oxycodone

(2008) Nora M. Hagelberg et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY